INSIGHTS ON CLINICAL TRIAL DESIGN
-
![The Pharmacy Advantage]( "The Pharmacy Advantage In Direct-To-Patient Clinical Supply")
The Pharmacy Advantage In Direct-To-Patient Clinical SupplyUnderstand state pharmacy regulations, prescription requirements, and operational considerations for shipping clinical supplies directly from pharmacies to patients' homes in decentralized trial models.
-
![GettyImages-1296415689 trial diversity]( "Practical Approaches To Clinical Trial Diversity")
Practical Approaches To Clinical Trial DiversityGain insights on FDA diversity action plans, and the important role that data points play in ensuring inclusion of underrepresented populations.
-
![early-oncology-trials-GettyImages-1796958784]( "Unanticipated Roadblocks In Ovarian Cancer Drug Development")
Unanticipated Roadblocks In Ovarian Cancer Drug DevelopmentEnhance your Ovarian cancer trials by enabling community referral pipelines, aligning imaging with biomarker assessments, and selecting sites based on verifiable surgical capacity.
-
![GettyImages-2148428939-computer-business-woman-office]( "Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures Everywhere")
Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures EverywhereOvercome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.
-
Mastering Precision Oncology Start-Up: Reducing Screening Delays3/30/2026
Biomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.
-
The Path Forward In Oncology Trials9/10/2025
A comprehensive site support model is crucial for navigating the complexities of modern oncology trials and accelerating drug development.
-
Breaking The Trial Bottleneck: Smarter, Faster Paths To Patients7/10/2026
AI is speeding clinical trials — but silos and complexity persist. Discover how connected systems and automation can enable faster, more adaptive development.
-
Designing Successful Cell And Gene Therapy Trials9/10/2025
Designing cell and gene therapy trials requires specialized strategies to navigate unique complexities, ensuring successful and compliant development.
-
Navigating Complexity In Master Protocols With Key Operational Partners7/5/2026
Complex adaptive trials offer real efficiency gains, but success hinges on having experienced partners to manage the operational details.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1212821220 diversity]( "Intelligent Trials - Diversity")
Medidata AI’s Intelligent Trials solution provides insights that allow you to take action to improve study diversity during the planning stages.
-
![GettyImages-1403159350 patient experience]( "Educate, Engage, Enroll: Accelerating Patient Recruitment")
Built on a globally compliant platform, explore a suite of technologies and services that sits at the crossroads of sponsors, recruitment partners, patients, HCPs, and trial sites.
-
![iStock-187467661-quality-control-inspection]( "Navigating The Use Of Controlled Substances In Clinical Trials Using IRT")
Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharma.
-
![GettyImages-1483234004-opthalmology-machine-eye-exam]( "Post-Marketing Studies And Real-World Evidence Clinical Trials")
Your trusted partner for decentralized post-marketing surveillance clinical trials and real-world evidence collection. Point-of-need accessibility. Proven compliance.
-
![GettyImages-2176126405-digital-puzzle]( "First-In-Human To Proof-Of-Concept: The DVCR Continuity Model")
With a single, consistent team from FIH to Proof-of-Concept, this Continuity Model eliminates fragmented handoffs to keep program knowledge intact and speed your path to Phase II.
